美股A股
StockGist
Back
8-K2026-03-12· grok-4-1-fast-non-reasoning

CADL · Candel Therapeutics, Inc.

0001193125-26-103126

SEC filing

Summary

Candel Therapeutics, Inc. announced its financial results for the quarter and year ended December 31, 2025 on March 12, 2026. The announcement is furnished under Item 2.02 with Exhibit 99.1 press release attached.

Key takeaways